BackInogen Overview

Inogen Current Cash

Track Inogen's current cash ($87M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$87.28M
↓ 15.83% YoYΔ $-16.41M vs prior year quarter

Peer average

Loading

Inogen Current Cash History

Loading

Inogen vs. peers: Current Cash Comparison

Loading

Inogen Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Inogen (INGN) FAQ

Inogen (INGN) currently reports a current cash of $87M as of June 2026. That compares with $100M in the prior-year period — down 15.8% year over year. Use the charts on this page to explore Inogen's current cash history and peer comparisons.

Inogen's current cash decreased from $100M to $87M — a 15.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Inogen reported $87M in current cash as of June 2026. That compares with $100M in the prior-year period — down 15.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $87M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Inogen, and consider following INGN for alerts when major investors trade the stock.

Inogen is classified in the Healthcare sector. On current cash, it currently shows $87M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INGN with unrelated industries.